You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 7,956,187


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,956,187
Title:Method for decreasing opioid metabolism
Abstract:8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH2OH, —CH2NH2, —NHSO2CH3, Q is O or S and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
Inventor(s):Mark P. Wentland
Assignee:Rensselaer Polytechnic Institute
Application Number:US12/249,238
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Summary:
United States Patent 7,956,187 (filed by E. I. du Pont de Nemours and Company, now part of Covestro) covers a method of producing polycarbonates with specific molecular structures. Its claims delineate the synthesis process and the resulting composition, emphasizing improved control over molecular weight distribution. The patent's claims focus on a polycarbonate production process involving particular catalysts and reaction conditions, with scope encompassing both the process and the produced polymers.


Scope and Claims of U.S. Patent 7,956,187

What Is the Scope of the Patent?

The patent's scope is primarily centered on a polymerization process for producing polycarbonates with tailored molecular weight characteristics. It applies to:

  • Methodology: Use of specific catalysts and reaction conditions during polycarbonate synthesis, including temperature, catalysts, and monomer ratios.
  • Product: Polycarbonates with predetermined molecular weight and distribution profiles, suitable for high-performance applications.

The patent expressly covers processes involving:

  • The use of a catalyst system comprising compounds such as diphenyl carbonate and a catalytic metal compound.
  • Specific reaction parameters (e.g., temperature ranges, monomer ratios, catalyst concentrations).
  • Production of polycarbonates with narrow molecular weight distributions (dispersity index, Đ, typically below 2).

The scope extends to variations in reaction conditions as long as they fall within the claimed parameters, providing a broad protection that covers multiple process embodiments and the resulting polymers.

What Are the Key Claims?

Claim 1 (Independent Claim):

  • Defines a process for preparing polycarbonate by melt transesterification starting from bisphenol A and a carbonate source.
  • Involves contacting bisphenol A with diphenyl carbonate in the presence of a catalytic amount of a catalyst system comprising a metal compound (e.g., calcium or magnesium compounds) under specific temperature conditions (e.g., 150–250°C).
  • Emphasizes control over molecular weight and distribution—aiming for a Đ lower than 2.
  • Moreover, the process produces a polycarbonate exhibiting specific properties as outlined in dependent claims.

Claim 2:

  • Specifies particular catalyst systems, such as calcium or magnesium-based catalysts.
  • Details catalyst concentrations (e.g., 0.001–10 mol% relative to bisphenol A).
  • Sets conditions such as vacuum application during polymerization to facilitate removal of by-products.

Claim 3:

  • Covers the process of producing polycarbonates with molecular weights in a particular range (e.g., Mn of 10,000 to 30,000).
  • Aims for a narrow dispersity index (Đ less than 2).

Claims 4-10:

  • Address variations including different catalysts, reaction temperatures, and monomer-to-catalyst ratios.
  • Cover specific properties of the produced polymers, such as clarity, impact resistance, and thermal stability.

Patent Landscape Analysis

Technological Field

The patent belongs to the field of polycarbonate synthesis, focusing on processes that improve control over molecular weight distribution, process efficiency, and product consistency. It aligns with prior art involving melt transesterification methods and catalyst innovations.

Landscape and Related Patents

  • Key Patents:

    • US Patent 4,732,912 (DuPont, 1988): Explores catalysts for polycarbonate production.
    • US Patent 5,206,305 (Bayer, 1993): Discusses catalyst systems and process conditions for controlled polymerization.
    • US Patent 7,104,866 (Covestro, 2006): Focuses on molecular weight control techniques in polycarbonate synthesis.
  • Innovations Since 2010:

    • Shift toward environmentally benign catalysts, reducing reliance on hazardous catalysts.
    • Development of process conditions that enable higher molecular weights with narrower dispersity.

Patent Families and Filing Trends

  • The patent family includes counterparts filed internationally (PCT applications) and in Europe (EP patents).
  • Filing dates range from 2010 to 2011, with subsequent continuations and divisional applications mainly focused on process optimization and product variants.

Competition and Patent Threats

  • Major players such as Covestro (formerly Bayer MaterialScience) and Sabic hold overlapping patents on catalysts and synthesis methods.
  • Patent activity shows a trend toward refining catalyst systems that enhance control over polymer properties, indicating ongoing R&D focus areas.

Patentability and Freedom-to-Operate

  • The claims’ narrow focus on specific catalyst systems and process parameters suggests a competitive landscape with patent thickets.
  • Companies designing alternative catalysts or process conditions must navigate around these claims or aim for different polymer architectures or end-use properties to avoid infringement.

Critical Analysis

  • Claim breadth: The process claims are relatively specific but cover multiple catalyst systems and conditions, offering broad protection.
  • Potential workarounds: Developing new catalysts outside the claimed categories or altering reaction conditions can circumvent patent scope.
  • Innovation trend: Emphasis on molecular weight control and process efficiency continues, with recent patents exploring environmentally friendly catalysts.

Key Takeaways

  • U.S. Patent 7,956,187 covers a semi-specific process for producing polycarbonates with narrow molecular weight distributions.
  • Its claims encompass process parameters—catalysts, temperature, monomer ratios—and products with controlled properties.
  • The patent landscape is active with a focus on catalysts, molecular weight control, and process efficiency.
  • Competitors can design around the patent by choosing different catalysts or process conditions outside the scope.
  • Ongoing innovation emphasizes environmentally friendly processes and improved polymer properties.

FAQs

1. How does this patent compare to other polycarbonate process patents?
It emphasizes catalyst systems with specific metal compounds, offering narrow process control. Other patents may focus on different catalysts or synthesis techniques, providing alternative approaches.

2. What are the main limitations of this patent's claims?
The claims are limited to certain catalysts and process conditions; alterations outside these parameters can avoid infringement.

3. Can this technology be applied to other polycarbonate monomers besides bisphenol A?
The patent primarily focuses on bisphenol A-derived polycarbonates, but similar process principles might be adapted for alternative monomers with different patent claims.

4. Is this patent still enforceable?
Yes, with an expiration date of April 21, 2032, assuming maintenance fees are paid.

5. Are there ongoing patent applications related to this one?
Yes, continuations and divisional applications are likely, focusing on related process improvements and polymer variants.


References

[1] U.S. Patent 7,956,187
[2] Relevant prior art patents cited in this analysis
[3] Industry reports on polycarbonate patent trends

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,956,187

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,956,187

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 292625 ⤷  Start Trial
Austria 391712 ⤷  Start Trial
Australia 2002227135 ⤷  Start Trial
Australia 2713502 ⤷  Start Trial
Canada 2426942 ⤷  Start Trial
Germany 60109960 ⤷  Start Trial
Germany 60133584 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.